Association of eGFR decline with dialysis and death in CKD stages 3∼5 cohort using univariate and multivariate cox proportional hazards analysis.

Model 1 is crude. Model 2 is further adjusted for age, gender, proteinuria, ACEI/ARB, antilipemic agents, diseases with a relatively large subgroup of patients (diabetic nephropathy, hypertensive nephropathy, IgA nephropathy, and membranous nephropathy).
HR, hazard ratio; C.I., confidence interval
Significant codes: *, <0.05; **, <0.01; ***, <0.001.

模型1为粗模型。模型2针对年龄、性别、蛋白尿、血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂（ACEI/ARB）、降脂药物，以及患者亚组规模较大的四类肾病（糖尿病肾病、高血压肾病、IgA肾病、膜性肾病）进行了进一步校正。
风险比（HR, hazard ratio）；置信区间（C.I., confidence interval）。
显著性标记规则如下：*表示P<0.05；**表示P<0.01；***表示P<0.001。